Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 1995
Ringed sideroblasts: a frequent observation after bone marrow transplantationW R Macon, K T Tham, J P Greer, et al.
American Journal of Clinical Pathology|July 1, 1990
Silver stain for ringed sideroblasts. A sensitive method that differs from Perls' reaction in mechanism and clinical applicationK T Tham, J B Cousar, W R Macon
Leukemia & Lymphoma|May 30, 2001
Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Leukemia & Lymphoma|June 28, 2001
Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Leukemia & Lymphoma|May 9, 2001
Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Bone Marrow Transplantation|February 16, 2000
Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patientsJ P Greer, W R Macon, R E Lamar, et al.
The American Journal of Surgical Pathology|March 1, 1995
Paracortical nodular T-cell lymphoma. Identification of an unusual variant of peripheral T-cell lymphomaW R Macon, M E Williams, J P Greer, et al.
The American Journal of Surgical Pathology|April 1, 1992
T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 casesW R Macon, M E Williams, J P Greer, et al.
Leukemia & Lymphoma|September 1, 1996
Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot studyR S Stein, J P Greer, J M Flexner, et al.
Pageof 19